438 related articles for article (PubMed ID: 8841510)
21. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
Lahiri T; Banerjee S; Dasgupta PS; Ray MR
Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
[TBL] [Abstract][Full Text] [Related]
22. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Xie QJ; Zhang X; Wang X; Bai L; Li HY
Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of experimental murine tumors by MT81, a new mycotoxin from Penicillium nigricans.
Gupta M; Majumdar UK; Ray MR; Mukhopadhayay DK
Neoplasma; 1997; 44(5):329-33. PubMed ID: 9473795
[TBL] [Abstract][Full Text] [Related]
24. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
26. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
27. Pt-ATP as an antineoplastic agent in an experimental mice model system.
Pal S; Mukherjea K; Bhattacharya R; Maity P
J Exp Clin Cancer Res; 1997 Sep; 16(3):255-60. PubMed ID: 9387898
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
31. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
33. Dependence on chain length of antitumor activity of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products.
Sasaki T; Abiko N; Sugino Y; Nitta K
Cancer Res; 1978 Feb; 38(2):379-83. PubMed ID: 620409
[TBL] [Abstract][Full Text] [Related]
34. In vivo tumor inhibitory and radiosensitizing effects of an Indian medicinal plant, Plumbago rosea on experimental mouse tumors.
Devi PU; Solomon FE; Sharada AC
Indian J Exp Biol; 1994 Aug; 32(8):523-8. PubMed ID: 7959931
[TBL] [Abstract][Full Text] [Related]
35. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
37. Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
Pütter J; Maral R; Bierling R; Steinhoff D
Farmaco Sci; 1971 Sep; 26(9):784-804. PubMed ID: 5157546
[No Abstract] [Full Text] [Related]
38. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
39. Isolation and purification of phosphate dependent glutaminase from sarcoma-180 tumor and its antineoplastic effects on murine model system.
Maity P; Chakraborty S; Bhattacharya P; Sarkar R
J Exp Clin Cancer Res; 1999 Dec; 18(4):475-80. PubMed ID: 10746973
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.
Sreelatha S; Padma PR; Umasankari E
J Ethnopharmacol; 2011 Apr; 134(3):984-7. PubMed ID: 21251969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]